Amanda Psyrri

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Squamous Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Myrto K Moutafi, Georgia-Angeliki Koliou, Georgios Papaxoinis, Panagiota Economopoulou, Ioannis Kotsantis, Maria Gkotzamanidou, Maria Anastasiou, Dimitrios Pectasides, Efthymios Kyrodimos, Alexander G Delides, Evangelos I Giotakis, Nikolaos G Papadimitriou, Ioannis G Panayiotides, Christos Perisanidis, Aileen I Fernandez, Vasiliki Xirou, Christos Poulios, Eleni Gagari, Vesal Yaghoobi, Niki Gavrielatou, Saba Shafi, Thazin Nwe Aung, Andromachi Kougioumtzopoulou, Vasileios Kouloulias, Konstantinos Palialexis, Stavros Gkolfinopoulos, Areti Strati, Evi S Lianidou, George Fountzilas, David L Rimm, Periklis G Foukas, Amanda Psyrri
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer. Cancer research communications 3 (8) (2023)
Niki Gavrielatou, Ioannis A Vathiotis, Thazin Nwe Aung, Saba Shafi, Sneha Burela, Aileen I Fernandez, Myrto K Moutafi, Barbara A Burtness, Panagiota Economopoulou, Maria Anastasiou, Periklis G Foukas, Amanda Psyrri, David L Rimm
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma. Cancer research communications 3 (4) (2023)
Kevin J Harrington, Barbara A Burtness, Richard Greil, Denis Soulieres, Makato Tahara, Gilberto de Castro Junior, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gumuscu, Ramona F Swaby, Danny Rischin
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Stefania Kokkali, Ioannis Kotsantis, Elpida Magou, Talagani Sophia, Theodoros Kormas, Giakoumis Diakoumis, Nikolaos Spathas, Amanda Psyrri, Alexandros Ardavanis
The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis. Investigational new drugs 40 (3) (2022)
Barbara A Burtness, Danny Rischin, Richard Greil, Denis Soulieres, Makato Tahara, Gilberto de Castro Junior, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Joy Ge, Ramona F Swaby, Burak Gumuscu, Kevin J Harrington
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)